Testing Design Thinking Methodology to Engage Hispanic and Latino Families of Autistic Children in Research.
NCT ID: NCT06111092
Last Updated: 2023-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
186 participants
INTERVENTIONAL
2024-02-01
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
Does the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaption using DT data yield higher scores of acceptability and implementation feasibility in comparison to FG methods?
Participants will:
* Be randomized into two groups of engagement (focus groups and design thinking)
* Be blinded (clinicians, selected caregivers, autistic persons, and cultural experts) and will rate the acceptability, feasibility, and cultural appropriateness of the protocol based on DT data higher than the protocol based on FG data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RCT of TeachTown in Autism Support Classrooms: Innovation and Exnovation
NCT02695693
Participation-based Intervention on Community Participation and Parent Empowerment for Children With ASD
NCT03721913
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
NCT02536365
Transitioning Together Boston
NCT05599711
Improving Academic and Social Functioning in Middle-Schoolers With Autism
NCT06705907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: A randomized mixed methods design is used to evaluate stakeholder engagement methods. Phase one will compare two stakeholder engagement methods (Design Thinking -DT, and Focus Group - FG) and evaluate stakeholder engagement based on the PCORI areas of stakeholder engagement which are operationalized in the Stakeholder-Centric Engagement Evaluation and qualitative data. Phase two utilizes data from phase one to culturally adapt the intervention (two separate intervention protocols will be adapted - one based on FG data and another based on DT data as described below), and obtain stakeholder input on acceptability and feasibility for the Hispanic/Latino autistic population. This provides a second way to measure the effectiveness of each stakeholder engagement method as we will have data to indicate which method (DT or FG) resulted in the highest-rated protocol. The data provided by this study will be used as a basis for a later comparative effectiveness study that will study the culturally adapted protocol's outcomes.
All sessions will be held in Spanish and/or English based on the groups' preferences. Since our intent is to hear the voices of Hispanic/Latino stakeholders, it seems valuable to hold focus groups in Spanish when the participants are Spanish as first language speakers (hereafter referred to as Spanish-first) with audio recordings and later transcription into English for analysis. To accommodate those who prefer English, we will make every effort to group these participants together. When, and if, the Spanish-first groups include participants who prefer English, we will have a Spanish to English translator available. In other words, we will be respectful of each participant's language to optimize their comfort in the engagement sessions.
This project addresses an urgent need to engage stakeholders as part of the research process from conceptualization to dissemination and the need for culturally sensitive evidence-based interventions for Hispanic/Latino autistic children. This project is being developed by a skilled and experienced team of investigators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Compare DT and FG on measures of stakeholder engagement
2. Compare the acceptability and feasibility of the adapted intervention manuals (one based on FG and another on DT data).
Design: A randomized mixed methods design is used to evaluate stakeholder engagement. Phase one will compare two stakeholder engagement methods (Design Thinking -DT, and Focus Group - FG) and evaluate stakeholder engagement. Phase two uses data from phase one to culturally adapt the intervention (two separate intervention protocols will be adapted, one from FG data and another from DT data) and obtain stakeholder input on acceptability and feasibility for the Hispanic/Latino population
OTHER
DOUBLE
* in Aim 2, the two adapted intervention protocols will be created, each based on data from either the design thinking or focus group sessions. These protocols will then be rated for acceptability, feasibility and cultural appropriateness using standardized measures and stakeholder input. This rating will be performed by individuals who are blinded to study arm that was used for adaptation of each protocol.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Design Thinking Group
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Design Thinking (DT) process.
Design Thinking
Participants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test.
Focus Group
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Focus Group (FG) process.
Focus Groups
Participants attend the FG that includes the introduction. discussion, and reflection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Design Thinking
Participants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test.
Focus Groups
Participants attend the FG that includes the introduction. discussion, and reflection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed diagnosis of autism spectrum disorder
* Hispanic/Latino
* received therapeutic services as a child; and
* willing and able (with i.e., language and cognitive skills) to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
* Parent/caregiver:
* Hispanic/Latino caregiver of an autistic child who receives or received therapeutic services such as occupational, physical, speech and language therapy
* willing to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Patient-Centered Outcomes Research Institute
OTHER
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roseann C Schaaf
Role: PRINCIPAL_INVESTIGATOR
Thomas Jefferson University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022C2-28939
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.